Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 3/20 | 0.83 |
| ▸ | NPY1R | P25929 | 2/20 | 0.83 |
| ▸ | NPY2R | P49146 | 2/20 | 0.83 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.60 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.55 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30358974 | 0.92 | NPY4R (0.82) | NPY4RNPY1RNPY2ROPRK1NPY5R | |
| SCHEMBL31151774 | 0.89 | NPY1R (0.72) | NPY4RNPY1RNPY2ROPRK1 | |
| SCHEMBL30565778 | 0.88 | NPY1R (0.69) | NPY4RNPY1RNPY2ROPRK1KISS1R | |
| SCHEMBL29604660 | 0.88 | NPY4R (0.74) | NPY4RNPY1RNPY2ROPRK1KISS1R | |
| SCHEMBL29364798 | 0.87 | NPY1R (0.77) | NPY4RNPY1RNPY2ROPRK1KISS1R | |
| SCHEMBL29354969 | 0.87 | NPY4R (0.67) | NPY4RNPY1RNPY2ROPRK1NPY5R | |
| SCHEMBL30114882 | 0.87 | NPY1R (0.69) | NPY4RNPY1RNPY2R | |
| SCHEMBL31151641 | 0.87 | NPY1R (0.69) | NPY4RNPY1RNPY2R | |
| SCHEMBL30496436 | 0.86 | NPY4R (0.65) | NPY4RNPY1RNPY2ROPRK1NPY5R | |
| SCHEMBL31152919 | 0.86 | OPRK1 (0.63) | NPY4RNPY1RNPY2ROPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4655309-A2 | PEPTIDE IN COMBINATION WITH FUNGICIDE COMPOSITIONS FOR FUNGAL CONTROL AND RELATED METHODS | Flagship Pioneering Innovations VII, LLC (US) | 2025-12-03 | — | — | EP | disclosed |
| US-20250287945-A1 | COMPOSITIONS FOR FUNGAL CONTROL AND RELATED METHODS | FLAGSHIP PIONEERING INNOVATIONS VII, LLC (US) | 2025-09-18 | — | — | US | disclosed |
| US-12329822-B2 | Antimicrobial tailored chitosan | UNIVERSITÉ DE GENVE (CH) | 2025-06-17 | — | — | US | disclosed |
| US-20250185669-A1 | ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME | Reactive Surfaces Ltd., LLP (US) | 2025-06-12 | — | — | US | disclosed |
| US-12232498-B2 | Anti-viral paints and coatings and articles comprising same | Reactive Surfaces Ltd., LLP (US) | 2025-02-25 | — | — | US | disclosed |
| US-20240309058-A1 | TUMOR HOMING AND CELL PENETRATING PEPTIDE-IMMUNO-ONCOLOGY AGENT COMPLEXES AND METHODS OF USE THEREOF | Blaze Bioscience, Inc. | 2024-09-19 | — | — | US | disclosed |
| WO-2024158837-A2 | PEPTIDE IN COMBINATION WITH FUNGICIDE COMPOSITIONS FOR FUNGAL CONTROL AND RELATED METHODS | FLAGSHIP PIONEERING INNOVATIONS VII, LLC (US) | 2024-08-02 | — | — | WO | disclosed |
| US-20240172762-A1 | ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME | Reactive Surfaces Ltd., LLP (US) | 2024-05-30 | — | — | US | disclosed |
| EP-4373840-A1 | COMPOSITIONS FOR FUNGAL CONTROL AND RELATED METHODS | Flagship Pioneering Innovations VII, LLC (US) | 2024-05-29 | — | — | EP | disclosed |
| US-11980192-B2 | Anti-viral paints and coatings and articles comprising same | Reactive Surfaces Ltd., LLP (US) | 2024-05-14 | — | — | US | disclosed |
| US-11832617-B2 | Anti-viral paints and coatings and articles comprising same | Reactive Surfaces Ltd., LLP (US) | 2023-12-05 | — | — | US | disclosed |
| US-20230270118-A1 | ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME | Reactive Surfaces Ltd., LLP (US) | 2023-08-31 | — | — | US | disclosed |
| WO-2023004435-A1 | COMPOSITIONS FOR FUNGAL CONTROL AND RELATED METHODS | FLAGSHIP PIONEERING INNOVATIONS VII, LLC (US) | 2023-01-26 | — | — | WO | disclosed |
| CN-110074179-B | Application of antibacterial peptide Jelleine-I in preparation of medicine for preventing and treating postharvest green mold of citrus fruits | 西南大学 | 2022-07-22 | — | — | CN | disclosed |
| CN-110063363-B | Antibacterial peptide O3TR and C12O3Application of TR (TR) in preparation of medicine for preventing and treating postharvest green mold of citrus fruits | 西南大学 | 2022-07-22 | — | — | CN | disclosed |
| US-20220193244-A1 | ANTIMICROBIAL TAILORED CHITOSAN | UNIVERSITE DE GENEVE (CH) | 2022-06-23 | — | — | US | disclosed |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2022-05-10 | — | — | US | disclosed |
| US-11304420-B2 | Anti-viral paints and coatings and articles comprising same | Reactive Surfaces Ltd., LLP (US) | 2022-04-19 | — | — | US | disclosed |
| US-20220087267-A1 | ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME | Reactive Surfaces Ltd., LLP (US) | 2022-03-24 | — | — | US | disclosed |
| US-11279941-B2 | Method for introducing protein into plant cell | RIKEN (JP) | 2022-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240309058-A1 | TUMOR HOMING AND CELL PENETRATING PEPTIDE-IMMUNO-ONCOLOGY AGENT COMPLEXES AND METHODS OF USE THEREOF | TAP1, CXCL12, CCL2 | NPY4R 878/4885NPY1R 573/4885NPY2R 877/4885 |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | HDGF, F11, F12 | NPY4R 1850/4885NPY1R 1306/4885NPY2R 1804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.